Date of Award

Spring 2026

Degree Type

Honors College Thesis

Academic Program

Biological Sciences BS

Department

Biological Sciences

First Advisor

Alexandre Marques

Advisor Department

Biological Sciences

Abstract

The lack of effective preventive measures for tick-borne diseases represents a major public health challenge. Transmission-blocking vaccines targeting tick molecules essential for feeding or reproduction could provide a sustainable and broad-spectrum solution. In this study, we evaluated two tick-derived proteins as potential vaccine antigens, subolesin, a key regulator of blood-feeding and cellular processes, and vitellogenin, a protein involved in egg development. Using bioinformatic tools, we identified immunogenic peptide sequences from each protein and chemically conjugated them to virus-like particles (VLPs) to enhance antigen presentation. C57BL/6 mice were immunized intradermally with VLP-peptide conjugates, followed by a booster dose. Blood and spleen samples were collected after the final immunization to evaluate humoral and cellular immune responses. Serum IgG levels were quantified by ELISA, and spleen cell supernatants were analyzed for cytokine production, including interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). Both peptide constructs elicited robust IgG antibody responses and significant IFN-γ production, while TNF-α levels were not significantly elevated. These findings suggest that the selected subolesin- and vitellogenin-derived peptide antigens induce strong humoral immunity and IFN-γ–associated cellular activation. The results provide encouraging preliminary evidence that these antigens are promising candidates for the development of transmission-blocking vaccines to control tick-borne diseases. Future work will include further immunological characterization and efficacy testing in challenge models.

Comments

Blanket Permission for Future Readers: Uncertain, please contact me with future requests at the following NON-USM email address: madelynalyssa7@icloud.com

Included in

Immunity Commons

Share

COinS